The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

30 articles for D Steinhilber


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Thermodynamic properties of leukotriene AEBI
Goethe-University Frankfurt
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators.EBI
Goethe-University Frankfurt
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.EBI
Goethe-University Frankfurt
Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.EBI
Goethe-University Frankfurt
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist.EBI
Goethe-University Frankfurt
Exploring the chemical space of multitarget ligands using aligned self-organizing maps.EBI
Goethe University
Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.EBI
Goethe-University Frankfurt
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors.EBI
Zafes/Liff/Osf Goethe-University Frankfurt
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.EBI
TBA
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.EBI
Zafes/Liff/Osf Goethe-University Frankfurt
A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.EBI
Goethe-University Frankfurt
SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.EBI
Zafes/Liff/Osf Goethe-University Frankfurt
Bioactivity-guided mapping and navigation of chemical space.EBI
Institut FüR Molekulare Physiologie
Development of a Potent and Selective G2A (GPR132) Agonist.EBI
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.EBI
Johann Wolfgang Goethe-UniversitäT
Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.EBI
Johann Wolfgang Goethe University
Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.EBI
Johann Wolfgang Goethe-UniversitäT
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.EBI
Goethe-University
Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.EBI
Fraunhofer Institute For Translational Medicine and Phamacology Itmp
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase.EBI
Goethe-University of Frankfurt
First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.EBI
Fraunhofer Ime
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.EBI
Goethe-University Frankfurt
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.EBI
Goethe-University Frankfurt
Structure optimization of a new class of PPARγ antagonists.EBI
Fraunhofer Institute For Molecular Biology and Applied Ecology Ime
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTAEBI
Goethe University Frankfurt
Computer-Aided Selective Optimization of Side Activities of Talinolol.EBI
Goethe-University of Frankfurt
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.EBI
Goethe University Frankfurt
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.EBI
Goethe-University Frankfurt
Arylpiperazine derivatives and methods of utilizing sameBDB
Reviva Pharmaceuticals
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.BDB
Abbott Laboratories